LOK Corporation is a manufacturer agent actively bringing innovative technologies to the international market. Lok Corporation has an extensive global network of distributors and regulatory partners that NGPOD will leverage to achieve fast and durable results in export markets.
John Carrington, CEO of NGPOD Global Ltd, said of the new agreement; "Our partnership with Lok Corporation will enable us to accelerate our plans to make NGPOD available globally in a way we could not have done using our internal resources only. We are getting fantastic responses from clinicians in every market we introduce NGPOD to but identifying partners and completing due diligence is very time-consuming. Lok will support us to achieve these processes, get agreements in place and onboard new distributors efficiently and thoroughly."
NGPOD Global Ltd is a UK-based medical device manufacturer. Strong growth domestically and burgeoning sales in initial international markets have already led to new high-quality life science manufacturing and operational support jobs at its Head Office and production unit in Cheshire.
The NGPOD system significantly improves patient safety concerning the placement and continued use of nasogastric feeding tubes. The use of nasogastric tubes is acknowledged globally as a patient safety risk as administration of hydration, nutrition or medication through a misplaced nasogastric tube can lead to death or significant patient injury. In addition, the current global pandemic has increased the use of nasogastric tubes, making NGPOD an even more vital tool to prevent unnecessary mortality and morbidity.
WHAT IS NGPOD?